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The in vitro antimicrobial activity of Justicia adhatoda, Glycyrrhiza glabra and Hyssopus officinalis 
extracts were studied against selected bacteria by using agar well diffusion assay. Methanol, ethanol, 
chloroform, diethyl-ether and aqueous extracts were tested in crude form for antibacterial activity 
against Bacillus subtillus, Escherichia coli, Pseudomonas aeruginosa, Salmonella typhimurium and 
Staphylococcus aureus. Maximum antibacterial activity was exhibited by all the three plant extracts. 
The results obtained with P. aeruginosa were particularly interesting since it was not inhibited by the 
antibiotic used but the tested plant extracts effectively inhibited the growth of P. aeruginosa. The 
methanolic extract of J. adhatoda was effective against S. typhimurium. All the plants extract in water 
were effective against spore forming of B. subtillus while S. aureus and E. coli were not effectively 
inhibited by extracts of tested plants. The results of analysis of variance have shown significant 
differences between the species, treatments and interaction between the species and treatments. 
However, the differences were non-significant between the treatments for G. glabra. The results indicate 
that J. adhatoda, G. glabra and H. officinalis present a noteworthy potential of antibacterial activities. 
 





There are 4,22,127 plant species growing on planet 
earth, about 35,000 to 70,000 plants species are used as 
medicinal plants (Hasan et al., 2007). Out of which 
20,000 plants species are believed to be used medici-
nally in the third world (Mukherjee, 2004). Approximately 
6000 species of flowering plants occur in Pakistan and 
700 of them have medicinal value (Shinwari et al., 2006; 
Stewart, 1972). Of these species, 500 are known for their 
active constituents from research conducted in Pakistan 
and elsewhere and around 250 to 300 species known to 
have entered the herbal market of Pakistan (Williams and 
Ahmad, 1999). It is important to mention that over 75% of 
population in Pakistan is cured by using traditional 
medicines prescribed by more than 50,000 traditional 
herb practitioners (Gill, 2003) and the folk knowledge of 
plant curing  pass  down  from  family  to  family  of  herb 
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The Word Health Organization (WHO) estimates that 
80% of world population use herbal medicines for some 
aspects of primary health care (Shinwari et al., 2006). 
While 70-80% of population in developing countries have 
often only traditional herbal remedies for their ailments, 
as they can not afford costly synthetic drugs (Al-Bashan, 
2006). The world has witnessed growing scientific and 
commercial interests in medicinal plants and plant-based 
products mainly due to their immense economic potential 
and widespread cultural acceptability (Ali and Jahangir, 
2001). But less than 5% species have been analyzed as 
potential medicine while rests of the 95% of plants are 
still there to be analyzed (Mukherjee, 2004).  
The different system of eastern medicines that is, Una-
ni, Ayurvedic and homeopathy, etc., are entirely based on 
medicinal properties of these plants. The practice of 
traditional medicine is widespread in China, India, Japan, 
Pakistan, Sri Lanka and Thailand (Hasan et al., 2007). 
Today herbal products and extracts are widely used to 
control various human diseases (Srinivasan et al., 2006). 
The use of plant extracts, as well as other alternative 






nowadays (Cowan, 1999). Promising bioassay results 
can be used to perform more exhaustive chemical, 
biological and pharmacological studies (Saupe, 2005). It 
has been reported that pharmacological properties of 
medicinal plants may leads in developing novel thera-
peutic agents (Hussain and Gorsi, 2004). The screening 
of plant extracts and plant products for antimicrobial 
activity has shown that higher plants represent a potential 
source of new anti-infective agents (De Smet, 1997; 
Cowan, 1999; Kelmanson et al., 2000; Srinivasan et al., 
2001). Plant extracts have great potential as antimicrobial 
compounds, especially in the treatment of infectious 
diseases caused by resistant microorganisms (Nasir and 
Chanda, 2006).  
Respiratory diseases, including allergies, asthma and 
chronic obstructive pulmonary disease (COPD) are a 
major public health burden worldwide. The latest WHO 
statistics (2007) estimate that 300 million people world-
wide have asthma, 210 million people have COPD and 
millions of people are affected by allergies. Each year, 
250,000 people die of asthma. The prevalence of these 
diseases is increasing and there is a continued need for 
new and improved therapies. The Nature Reviews Immu-
nology focused this issue and highlights the latest 
advances in our understanding of the immune bases of 
these respiratory diseases and how this knowledge can 
be translated into effective treatment strategies (http:// 
www.nature.com/nri/focus/allergyandasthma/index. html).  
Some respiratory diseases are caused by bacteria. For 
instance, Staphylococcus aureus causes pneumonia 
(Rubinstein et al., 2008), Escherichia coli causes commu-
nity-acquired pneumonia (Tillotson and Lerner, 1967), 
Bacillus subtilis causes occupational asthma (Chan-
Yeung and Lam, 1986) which is a reason for allergic 
reactions of the lungs (Pepys et al., 1969), Salmonella 
typhimurium causes lobar pneumonia (Mankhambo et al., 
2006) and Pseudomonas aeruginosa typically infects the 
pulmonary tract and cause pneumonia (Grant et al., 
2000).  
The leaves of Justicia adhatoda have been in use in 
Indian systems of medicine for the last more than 2000 
years. J. adhatoda is well known in the indigenous sys-
tems of medicine for its beneficial effects, particularly in 
bronchitis (Claeson and Malmfors, 2000). The leaves, 
flowers, fruits and roots are extensively used for treating 
cold, cough, whooping-cough (Dhuley, 1999) and chronic 
bronchitis and asthma as sedative-expectorant, anti-
spasmodic and as anthelmintic. The bronchodilatiry and 
expectorant properties of the leaves are attributed to 
vasicine (Chatterjee, 1999). Warm Decoction of the 
leaves was expectorant and cured asthma patients 
(Mahato and Chaudhary, 2005). 
The root of the Glycyrrhiza has wide range of thera-
peutic properties from centuries (Tsukiyama, 2002). Gly-
cyrrhizin and glycyrrhizic acid have been shown to inhibit 
growth and cytopathology of cytomegalovirus (Numazaki 
et al., 1994). Liquorice root is  used  in  cough  medicines 




and also in the treatment of catarrhal infections of the 
urinary tract (Grieve, 1984). It is taken internally in the 
treatment of asthma, bronchitis, coughs, peptic ulcer, 
arthritis and allergic complaints (Bown, 1995).  
Hyssop derived from Hyssopus officinalis has a long 
history of medicinal use (Chevallier, 1996). Currently it is 
often used as a household remedy, as an expectorant 
and stomach tonic (Grieve, 1984) and to treat bronchitis 
and respiratory infections with excessive mucous produc-
tion (Chevallier, 1996). A tea made from the leaves is 
used in the treatment of flatulence, stomachaches, upper 
respiratory tract infections, coughs in children, etc (Bown, 
1995).  
The main objective of the present study was to investi-
gate the in vitro antimicrobial activity of, J. adhatoda, 
Glycyrrhiza glabra and H. officinalis extracts on five 
bacterial species causing various respiratory diseases. 
These plants have been used for centuries by native 
people of Pakistan to cure the diseases of pulmonary 
tract like pneumonia, bronchitis, cough, cold and asthma. 
The screening of these plants as new anti-infective 
agents in respiratory diseases will give scientific evidence 
for the culturally acceptable medicinal plants for respire-
tory diseases. It will boost the production of plant-based 
products by pharmaceutical industries and will prospe-
rous the economy of third world countries like Pakistan. 
 
 
MATERIALS AND METHODS  
 
Plant collection and extract preparation 
 
Dried medicinal plant materials were collected from natural medi-
cine laboratory at Qarshi Research International (QRI), Qarshi 
Industries Hattar Haripur, NWFP, Pakistan and identified by Profes-
sor Dr. Abdul Rashid, Plant Taxonomist, Botany Department, 
University of Peshawar, NWFP. The plant parts were placed in a 
beaker and kept in oven for 10 min at 100°C for drying and then 
ground to fine powder in blender. 
Extract of each plant was prepared by soaking five grams of plant 
material in 20 ml of five solvents; methanol (T1), ethanol (T2), 
chloroform (T3), diethyl-ether (T4) and double distilled water (T5) 
and placed at ambient temperature for 48 h. The extracts were then 
filtered by using soaked whatman filter paper with the respective 
solvent. The extracts were centrifuged at 5000 rpm for 5 min; super-




Selection of test organisms  
 
Gram-positive bacteria, Staphylococcus aureus, Bacillus subtilis, 
Gram-negative bacteria, Pseudomonas aeruginosa, Escherichia 
coli and S. typhimurium were obtained from culture library of Micro-
biology Laboratory of QRI and were checked for purity by colonial 
morphology and biochemical tests. Pure culture were grown in 





Antibacterial activity of the extracts was tested on the selected 
organism of  Gram-positive  and  Gram-negative  bacteria  by  Agar  
 




Table 1. Analysis of variance for Hyssopus officinalis. 
 
Source DF SS MSS F-Value P 
Treatments 4 316.83 79.20 20.58*** 0.0000 
Species 4 102.40 25.60 6.65*** 0.0002 
Treatment X species 16 161.35 10.08 2.62*** 0.0048 
Error 50 192.38 3.84 - - 
 





Table 2. Analysis of variance for Justicia adhatoda. 
 
Source DF SS MSS F-Value P 
Treatments 4 210.09 52.52 10.38 *** 0.0000 
Species 4 107.42 26.85 5.31*** 0.0012 
Treatment X species 16 434.58 27.16 5.37*** 0.0000 
Error 50 252.98 5.06 - - 
 





Table 3. Analysis of variance for Glycyrrhiza glabra. 
 
Source DF SS MSS F-Value P 
Treatments 4 43.64 10.91 2.64 NS 0.0447 
Species 4 851.69 212.92 51.48*** 0.0000 
Treatment x species 16 476.24 29.76 7.19*** 0.0000 
Error 50 206.80 4.14 - - 
 





well diffusion method. The nutrient agar medium was prepared by 
using 10 g/l agar technical (Oxoid UK) and 8 g/l nutrient broth 
(Merck Germany), at pH 7.3. 20 ml of nutrient agar medium was 
poured into each Petri plate of 20 x 90 mm and allowed to cool up 
to 45°C to solidify. 50 µl of culture was poured and evenly spread 
on the medium using sterile steel spreader. Five wells of 8 mm 
diameter were made in the agar by using a sterile cork borer. 100 µl 
of plant extract was loaded in each well with the help of micro-
pipette. A control antibiotic disc of 30 µg chloramphenicol was also 
used to compare the activity of plant extract with antibiotics. The 
plates were incubated at 35°C in three replications in the incubator 
for 24 h. Zone of inhibition was measured for each extract using 
digital vernier caliper and the results were recorded. 
 
 
RESULTS AND DISCUSSION 
 
The results of antibacterial activity of each extract were 
recorded after measuring the zone of inhibition in each 
replication. The data was subjected to two way analysis 
of variance and LSD test was applied to test the variation 
in treatments and species. 
The antibacterial activity of the solvents was deter-
mined in pure form prior to plant extract preparation. 
Ethanol and chloroform exhibited antibacterial activity in 
pure form; therefore the zone of inhibition was adjusted 
by subtracting the control solvent activity from the zone of 
corresponding solvent’s plant extract. A control antibiotic 
disc of 30 µg chloramphenicol was used to compare the 
activity of plant extract. Chloramphenicol also inhibited 
the tested pathogens except P. aeruginosa. 
Chloroform in pure form also inhibited the growth of all 
tested pathogens; the zones of inhibition against E. coli, 
S. typhimurium, S. aureus, P. aeruginosa and Bacillus 
subtillus were 12.21 ± 0, 10.11 ± 0, 13 ± 0, 10 ± 0 and 
11.63 ± 0 mm respectively. The zones of inhibition of 
chloramphenical against E. coli, S. typhimurium, S. 
aureus and B. subtillus were 26.31 ± 0, 22 ± 0, 29 ± 0 
and 28.14 ± 0, respectively.  
The data was subjected to two way analysis of 
variance. The results indicated highly significant variation 
between the treatments and species and interaction 
between the treatments x species for H. afficinalis and J. 
adhatoda (Tables 1 and 2). Whereas the variations were 
non-significant between the treatments but significant for 
species and treatments x species for G. glabra  (Table 3).  
 




Table 1a. LSd test for variance. 
 
Treatment T1 T2 T3 T4 T5 
Mean 14.58 12.59 10.45 8.00 8.00 
Grouping A                     AB 
                                            BC         
                                                                 C                 C 
 






















LSD test also showed significant variations between the 
treatments for H. officinalis and J. adhatoda (Tables 1a 
and 2a). However, the variation in treatment was non-
significant in G. glabra (Table 3a). 
J. adhatoda exhibited maximum antibacterial activity 
against B. subtillus producing a maximum zone of inhibit-
tion (17.78 mm). This antibacterial activity against gram 
positive bacteria is due to the presence of flavonoids 
(Ahmed and Abd, 1999; Shinwari et al., 2006), alkaloids 
(Brantner and Chakraborty, 1998; Foster and Duke, 
1990) or polysaccharides and polypeptides (Cowan, 
1999). It may be possible that the extract contain certain 
compounds which inhibit the cell wall synthesis of 
bacteria. Methanolic extract of J. adhatoda exhibited 
positive antimicrobial activity for P. aeruginosa, S. aureus 
and B. subtillus. Similar results were reported by Mahato 
and Chaudhary (2005) with disk diffusion method. 
The wide range of therapeutic properties of the root of 
Glycyrrhiza is well known (Tsukiyama, 2002). G. glabra 
exhibited antibacterial activity against spore forming of B. 
subtillus; the spore formation was inhibibited to various 
degrees in all plant extracts except chloroform extract. 
Our results correspond with Mowrey (1986) that the 
alcoholic extracts of Glycyrrhiza have displayed anti-
microbial activity. Murray (1985) reported the antibacterial 
activity due to the presence of isoflavonoid-hispagla-
bridin and B, 4’-O-methylglabridin, glabridin, glabriol and 
3-hydroxyglabrol; whereas He et al. (2006) indicated the 
antibacterial activity due to pterocarpenes - glycyrrhizol A 
and glycyrrhizol B and Tsukiyama (2002) reported the 
presence of Licochalcone A.  
The results of the present study correspond with the 
findings of Gruenwald (2000), Jankovsky and Landa 
(2002) that the methanolic extract of H. afficinalis showed 
broad spectrum antibacterial activity against B. subtillus 
and P. aeruginosa. Mean zone of inhibition was more 
than 14.58 mm, which is due to the presence of volatile 
oil (Hilal et al., 1978) containing pinocamphone and iso-
pinocamphone linalol, 1,8-cineole and limonene 
(Mazzanti et al., 1998), tannins, marubiin, flavonoids 
(glycosides of hesperidin and diosmetin) (Gruenwald, 
2000). The organic extraction of plant showed greater 
activity than aqueous extract. Most of the antibacterial 
principles were either polar or non-polar and were 
extracted through the organic solvent medium as shown 
by Britto (2001). Similar results were shown by Krishna et 
al. (1997) and Singh and Singh, (2000). P. aeruginosa 
showed resistance to chloramphenicol which indicates 
the plant extract has great potential as antimicrobial com-
pounds, especially in the treatment of infectious diseases 
caused by resistant microorganism (Nasir and Chanda, 
2006). 
The tested plant extracts have great potential as 
antimicrobial compounds   having  the  potential  as  anti- 
Treatment T3 T1 T5 T2 T4 
Mean 17.78 13.78 10.00 9.78 8.00 
Grouping A         
                B 
                                   C          C          C 
Treatment T4 T5 T1 T2 T3 
Mean 8.30 8.20 8.10 8.10 8.00 
Grouping A              A                   A                 A                  A 
 




microbial compounds, the test plant extracts can be used 
in the treatment of respiratory infections caused by tested 
microbes. The screening of these plant extracts, as a 
source of new anti-infective agents confirms the know-
ledge of traditional herb practitioners. These findings will 
not only authenticate the traditional knowledge of folk 
healers but it will also interest pharmaceutical industries 
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